Point-of-Care (POC) Test Development Services

Elevate your point-of-care (POC) diagnostics with a partner that’s done it for over 27 years. Future Diagnostics designs and develops high performance POC assays for a wide range of platforms and clinical applications across the IVD market. From whole blood immunoassays and dried reagent cartridges to precision miniaturization and magnetic bead workflows, we develop assays to deliver quantitative, rapid, and reliable results where they matter most—at the patient’s side.

Future Diagnostics | All services | Point-of-Care Test Development

Our POC development expertise

For more than a decade, our multidisciplinary team has developed quantitative POC assays across diverse devices and clinical needs. We specialize in various sample matrices including, detection methodologies and reagent formulations, tailoring each solution to your target biomarkers, sample matrix, and user environment. We help you reach the performance required for confident decisions at the point of care. What sets us apart is our end-to-end capability—from feasibility and reagent screening to optimization, verification, and transfer—combined with a deep understanding of the practical realities of decentralized testing, including usability, stability, and manufacturability.

Why point-of-care testing matters

POC testing brings rapid, actionable insights to near-patient settings such as clinics, emergency departments, urgent care, physician offices, and even retail health. Compared with central lab workflows, POC tests can shorten time-to-result from hours to minutes, improving decision-making, patient experience, and operational efficiency. Authoritative programs emphasize that effective POC diagnostics should be rapid, sensitive, specific, easy-to-use, and cost-effective, with integrated, sample- to-answer workflows wherever possible.

Our Key capabilities

Immunoassays for multiple matrices: We develop sensitive assays for whole blood, serum, plasma, saliva, and urine.

We work with your team at different stages of development: from novel assay development for existing systems to initial co-development of platforms and assays from the ground up. All with a strong collaborative approach and clear feedback between teams.

Our workflows are optimized to quantify low-abundance biomarkers in small sample volumes, often from a single drop.

Dried reagent chemistry workflows: We formulate stable, dry reagents that rehydrate instantly upon sample contact to achieve rapid reaction kinetics. This enables simpler cartridges, fewer handling steps, and improved shelf life without cold-chain constraints.

Extensive bead selection: Bead selection is a decisive parameter for sensitivity, specificity, and dynamic range. We evaluate magnetic, colloidal gold, and fluorescent particles—often under 1 µm—optimize coatings (antibodies/antigens), and match bead chemistry to your detection modality and cartridge design.

We prioritize key assay parameters such as detection capability, precision, lot-to-lot consistency
and stability from the outset to mitigate the risk of major design changes downstream the
development process.

Objective guidance on platform and pathway

Selecting the right device architecture can make or break POC success. If you are weighing options—lateral flow vs. microfluidics, reader-based fluorescence vs. colorimetric, disposable vs. semi- reusable—we provide objective, data-driven recommendations aligned to your biomarker biology, target performance, cost, and user setting. Our advice is custom to your requirements, not tied to any single platform.

Collaboration and transparency
Our clients work closely with a strong scientific team of IVD professionals who bring assay chemistry, engineering, and manufacturing experience together. You get clear milestones, proactive communication, and data-backed decisions from feasibility through verification and transfer.

Let’s build your next POC test

Whether you’re enhancing an existing device or launching a new platform, Future Diagnostics is your partner for rigorous, result-driven POC development. Share your biomarker, target performance, and use case, and we will propose a tailored plan to get you from concept to clinic ready assay.